Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Norman Putzki"'
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0125002 (2015)
Patient-reported outcomes are increasingly used to understand the clinical meaningfulness of multiple sclerosis disability and its treatments. For example, the 12-item Multiple Sclerosis Walking Scale (MSWS-12) measures the patient-reported impact of
Externí odkaz:
https://doaj.org/article/6db9ce67393a44b9aa94e06432d6f1d2
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 4 (2011)
Interferon beta preparations are the most widely used initial therapies prescribed for patients with relapsing–remitting multiple sclerosis. Phase III studies have demonstrated comparable efficacy on clinical measures of disease activity, variable
Externí odkaz:
https://doaj.org/article/59129e3381d94d98ac8e65d6a7a5932b
Autor:
Özgür Yaldizli, Norman Putzki
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 2 (2009)
Natalizumab reduced the rate of clinical relapse at one year by 68% and the risk of sustained progression of disability by 42—54% over 2 years in its pivotal phase III trial (AFFIRM) in relapsing—remitting multiple sclerosis (RRMS). Natalizumab i
Externí odkaz:
https://doaj.org/article/ac55ebbd9678419da2020a9b87054d61
Autor:
Stephanie Glassl, Dietrich Sturm, Achim Gass, Ramin Atefy, Norman Putzki, Barbara Tettenborn, Özgür Yaldizli
Publikováno v:
Yaldizli, Ozgür; Atefy, Ramin; Gass, Achim; Sturm, Dietrich; Glassl, Stephanie; Tettenborn, Barbara; Putzki, Norman (2010). Corpus callosum index and long-term disability in multiple sclerosis patients. Journal of neurology, 257(8), pp. 1256-1264. Heidelberg: Springer-Medizin-Verlag 10.1007/s00415-010-5503-x
Prediction of long-term disability in patients with multiple sclerosis (MS) is essential. Magnetic resonance imaging (MRI) measurement of brain volume may be of predictive value but sophisticated MRI techniques are often inaccessible in clinical prac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::245850e07979e67a36106a33ddd59347
http://doc.rero.ch/record/317369/files/415_2010_Article_5503.pdf
http://doc.rero.ch/record/317369/files/415_2010_Article_5503.pdf
Autor:
Goeril Karlsson, Tanuja Chitnis, Dieter A. Häring, Jutta Gärtner, Daniela Pohl, Wolfgang Brück, Norman Putzki, Angelo Ghezzi
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Background Disease activity differs in young patients with multiple sclerosis (MS) compared with the overall adult MS population. Objective The objective of this paper is to evaluate the effect of fingolimod 0.5 mg on disease activity in young adults
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45e7f70407a4a774ae0ce69836bbd972
http://europepmc.org/articles/PMC5971396
http://europepmc.org/articles/PMC5971396
Autor:
Howard L. Weiner, Ludwig Kappos, Martin Merschhemke, Catherine Lubetzki, David G. MacManus, David Miller, Fred D. Lublin, Bruce A.C. Cree, Hans-Peter Hartung, Tarek A. Yousry, Bernard M. J. Uitdehaag, Norman Putzki, Xavier Montalban, Claudia A. M. Wheeler-Kingshott, Dieter A. Häring, Bingbing Li, Özgür Yaldizli, Maria Pia Sormani, Jerry S. Wolinsky, Mark S. Freedman
Publikováno v:
Annals of clinical and translational neurology, vol 5, iss 3
Miller, D H, Lublin, F D, Sormani, M P, Kappos, L, Yaldizli, Ö, Freedman, M S, Cree, B A C, Weiner, H L, Lubetzki, C, Hartung, H-P, Montalban, X, Uitdehaag, B M J, MacManus, D G, Yousry, T A, Gandini Wheeler-Kingshott, C A M, Li, B, Putzki, N, Merschhemke, M, Häring, D A & Wolinsky, J S 2018, ' Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study ', Annals of Clinical and Translational Neurology, vol. 5, no. 3, pp. 346-356 . https://doi.org/10.1002/acn3.534
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, 5(3), 346-356. John Wiley and Sons Ltd
Miller, D H, Lublin, F D, Sormani, M P, Kappos, L, Yaldizli, Ö, Freedman, M S, Cree, B A C, Weiner, H L, Lubetzki, C, Hartung, H-P, Montalban, X, Uitdehaag, B M J, MacManus, D G, Yousry, T A, Gandini Wheeler-Kingshott, C A M, Li, B, Putzki, N, Merschhemke, M, Häring, D A & Wolinsky, J S 2018, ' Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study ', Annals of Clinical and Translational Neurology, vol. 5, no. 3, pp. 346-356 . https://doi.org/10.1002/acn3.534
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, 5(3), 346-356. John Wiley and Sons Ltd
Author(s): Miller, David H; Lublin, Fred D; Sormani, Maria Pia; Kappos, Ludwig; Yaldizli, Ozgur; Freedman, Mark S; Cree, Bruce AC; Weiner, Howard L; Lubetzki, Catherine; Hartung, Hans-Peter; Montalban, Xavier; Uitdehaag, Bernard MJ; MacManus, David G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86c172344bc563c9878856859d2a89d8
https://escholarship.org/uc/item/4nw4r8gf
https://escholarship.org/uc/item/4nw4r8gf
Autor:
Patrick Vermersch, Norman Putzki, Ernst-Wilhelm Radue, Martin Merschhemke, Shannon Ritter, Mark S. Freedman
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Background Cases of higher-than-expected disease activity have been reported following fingolimod discontinuation. Objective The objective of this paper is to assess the risk of substantially higher-than-expected disease activity post-study drug disc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d65487cbc0c87b1e9db47d3b6185538
https://pubmed.ncbi.nlm.nih.gov/28989795
https://pubmed.ncbi.nlm.nih.gov/28989795
Autor:
Esther Ruberte, Özgür Yaldizli, J. Würfel, Norman Putzki, Jens Kuhle, M Pardini, C. Valmaggia, D. Botzkowski, Achim Gass, Jochen Vehoff, Stefanie Müller, Barbara Tettenborn
BACKGROUND AND PURPOSE N-acetyl aspartate (NAA) assessed using proton magnetic resonance spectroscopy (1 H MRS) has a high pathological specificity for axonal density. Retinal nerve fibre layer thickness (RNFLT) measured by using optical coherence to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f867ecd749c46fa767804057d3a9cdab
http://hdl.handle.net/11567/855078
http://hdl.handle.net/11567/855078
Publikováno v:
Expert Review of Clinical Pharmacology. 5:649-665
Multiple sclerosis is a progressive demyelinating neurological disease resulting in long-term disability, commonly manifesting in walking impairment and reduced quality of life. The use of the potassium channel blocker fampridine, chemically 4-aminop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b26120ae731f0feab328f0794455a675
https://doi.org/10.1586/ecp.12.59
https://doi.org/10.1586/ecp.12.59
Autor:
S. Cursiefen, Barbara Tettenborn, M. Mäurer, S. Kuckert, Norman Putzki, Volker Limmroth, Özgür Yaldizli, C. Klawe, Matthias Maschke
Publikováno v:
European Journal of Neurology. 17:31-37
Background: Natalizumab has been recommended for the treatment of relapsing–remitting multiple sclerosis (RRMS) in patients with insufficient response to interferon-beta/glatiramer acetate (DMT) or aggressive MS. The pivotal trials were not conduct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1590307d812955efe8117029ccc93cf
https://doi.org/10.1111/j.1468-1331.2009.02728.x
https://doi.org/10.1111/j.1468-1331.2009.02728.x